The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer

European Journal of Surgical Oncology

Volumn 35, Issue 3, 2009, Pages 276-280

  van de Vrande, S ^a   Meijer, J ^a   Rijnders, A ^a   Klinkenbijl, J H G ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Breast cancer; Frozen section; Intraoperative; Sentinel lymph node

Indexed keywords

HEMATOXYLIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 59649095933     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.07.016     Document Type: Article

References (44)

1. Ivens D., Hoe A.L., Podd T.J., Hamilton C.R., Taylor I., and Royle G.T. Assessment of morbidity from complete axillary dissection. Br J Cancer 66 1 (1992) 136-138
2. Lucci A., McCall L.M., Beitsch P.D., et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011. J Clin Oncol (2007)
3. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23 19 (2005) 4312-4321
4. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 9069 (1997) 1864-1867
5. Turner R.R., Ollila D.W., Krasne D.L., and Giuliano A.E. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226 3 (1997) 271-276
6. Giuliano A.E., Jones R.C., Brennan M., and Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15 6 (1997) 2345-2350
7. Viale G., Maiorano E., Pruneri G., et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241 2 (2005) 319-325
8. Kim T., Giuliano A.E., and Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106 1 (2006) 4-16
9. Albertini J.J., Lyman G.H., Cox C., et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276 22 (1996) 1818-1822
10. Fisher B., Redmond C., Fisher E.R., et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312 11 (1985) 674-681
11. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 14 (1997) 956-962
12. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial. N Engl J Med 337 14 (1997) 949-955
13. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 9165 (1999) 1641-1648
14. Fisher B., Jeong J.H., Anderson S., Bryant J., Fisher E.R., and Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347 8 (2002) 567-575
15. Weiser M.R., Montgomery L.L., Susnik B., Tan L.K., Borgen P.I., and Cody H.S. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?. Ann Surg Oncol 7 9 (2000) 651-655
16. Flett M.M., Going J.J., Stanton P.D., and Cooke T.G. Sentinel node localization in patients with breast cancer. Br J Surg 85 7 (1998) 991-993
17. Nagashima T., Suzuki M., Yagata H., et al. Intraoperative cytologic diagnosis of sentinel node metastases in breast cancer. Acta Cytol 47 6 (2003) 1028-1032
18. Tanis P.J., Boom R.P., Koops H.S., et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 8 3 (2001) 222-226
19. van Diest P.J., Torrenga H., Borgstein P.J., et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 35 1 (1999) 14-18
20. Motomura K., Inaji H., Komoike Y., et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg 87 5 (2000) 597-601
21. Dixon J.M., Mamman U., and Thomas J. Accuracy of intraoperative frozen-section analysis of axillary nodes. Edinburgh Breast Unit team. Br J Surg 86 3 (1999) 392-395
22. Hill A.D., Tran K.N., Akhurst T., et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 229 4 (1999) 528-535
23. Viale G., Bosari S., Mazzarol G., et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85 11 (1999) 2433-2438
24. Schreiber R.H., Pendas S., Ku N.N., et al. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol 6 1 (1999) 95-101
25. Celebioglu F., Sylvan M., Perbeck L., Bergkvist L., and Frisell J. Intraoperative sentinel lymph node examination by frozen section, immunohistochemistry and imprint cytology during breast surgery-a prospective study. Eur J Cancer 42 5 (2006) 617-620
26. Goyal A., Newcombe R.G., and Mansel R.E. Clinical relevance of multiple sentinel nodes in patients with breast cancer. Br J Surg 92 4 (2005) 438-442
27. McCarter M.D., Yeung H., Fey J., Borgen P.I., and Cody III H.S. The breast cancer patient with multiple sentinel nodes: when to stop?. J Am Coll Surg 192 6 (2001) 692-697
28. Turner R.R., Hansen N.M., Stern S.L., and Giuliano A.E. Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol 112 5 (1999) 627-634
29. Rubio I.T., Korourian S., Cowan C., Krag D.N., Colvert M., and Klimberg V.S. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 5 8 (1998) 689-694
30. Kane III J.M., Edge S.B., Winston J.S., Watroba N., and Hurd T.C. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol 8 4 (2001) 361-367
31. Ratanawichitrasin A., Biscotti C.V., Levy L., and Crowe J.P. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer. Br J Surg 86 10 (1999) 1346-1348
32. Scucchi L.F., Di S.D., Cosentino L., and Vecchione A. Value of cytology as an adjunctive intraoperative diagnostic method. An audit of 2250 consecutive cases. Acta Cytol 41 5 (1997) 1489-1496
33. Pugliese M.S., Kohr J.R., Allison K.H., Wang N.P., Tickman R.J., and Beatty J.D. Accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer. Am J Surg 192 4 (2006) 516-519
34. Greco M., Agresti R., Cascinelli N., et al. Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg 232 1 (2000) 1-7
35. la Rovere G.Q., Bonomi R., Ashley S., and Benson J.R. Axillary staging in women with small invasive breast tumours. Eur J Surg Oncol 32 7 (2006) 733-737
36. Cserni G., Bianchi S., Vezzosi V., et al. Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study. Pathol Oncol Res 13 1 (2007) 5-14
37. Cox C.E., Pendas S., Cox J.M., et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227 5 (1998) 645-651
38. Silverstein M.J., Gierson E.D., Waisman J.R., Senofsky G.M., Colburn W.J., and Gamagami P. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?. Cancer 73 3 (1994) 664-667
39. Cserni G., Gregori D., Merletti F., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91 10 (2004) 1245-1252
40. Viale G., Maiorano E., Mazzarol G., et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92 6 (2001) 1378-1384
41. Chu K.U., Turner R.R., Hansen N.M., Brennan M.B., Bilchik A., and Giuliano A.E. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?. Ann Surg 229 4 (1999) 536-541
42. Calhoun K.E., Hansen N.M., Turner R.R., and Giuliano A.E. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 190 4 (2005) 588-591
43. Bolster M.J., Bult P., Schapers R.F., et al. Differences in sentinel lymph node pathology protocols lead to differences in surgical strategy in breast cancer patients. Ann Surg Oncol 13 11 (2006) 1466-1473
44. Imoto S., Ochiai A., Okumura C., Wada N., and Hasebe T. Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining. Eur J Surg Oncol 32 10 (2006) 1175-1179